F. Miesowicz

Clinical regressions and broad immune activation following combination therapy targeting human NKT cells in myeloma

Joshua Richter, Natalia Neparidze, Lin Zhang et al. · Blood · 2012 · 166 citations · Full text

Medicine, Immunology, Oncology +16

SAT0193 Results of a randomized placebo controlled phase ia study of AGS-009, a humanized anti-interferon-α monoclonal antibody in subjects with systemic lupus erythematosus

Irina Y. Tcherepanova, Morgan Curtis, Michèle M. Sale et al. · Annals of the Rheumatic Diseases · 2012 · 34 citations

Life Sciences, Immunology, Pharmacology +16

Phase II study combining personalized dendritic cell (DC)-based therapy, AGS-003, with sunitinib in metastatic renal cell carcinoma (mRCC).

Robert A. Figlin, Asim Amin, Arkadiusz Z. Dudek et al. · Journal of Clinical Oncology · 2012 · 22 citations

Medicine, Immunology, Oncology +14

Monitoring T-cell responses in a phase II study of AGS-003, an autologous dendritic cell-based therapy in patients with newly diagnosed advanced stage renal cell carcinoma in combination with sunitinib.

Robert A. Figlin, Charles A. Nicolette, Alpesh Amin et al. · Journal of Clinical Oncology · 2011 · 21 citations

Medicine, Immunology, Oncology +17